Inventor · disambiguated record
Jan Torleif Pedersen
Also filed as: PEDERSEN JAN T · PEDERSEN JAN TORLEIF
12 granted patents·6 pending applications·993 citations·filing 1992–2024
92Inventor score
Top patents by PatentIndex Score
18 records- 0197US5639641AResurfacing of rodent antibodiesIMMUNOGEN INC·Filed 1992·Granted Jun 17, 1997·870 cites·16 claims
- 0295US11111290B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2019·Granted Sep 7, 2021·6 cites·9 claims
- 0395US10196439B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2016·Granted Feb 5, 2019·23 cites·20 claims
- 0494US10934348B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2019·Granted Mar 2, 2021·6 cites·11 claims
- 0592US10647762B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2019·Granted May 12, 2020·5 cites·3 claims
- 0690US10995137B2Antibodies specific for hyperphosphorlated tau for the treatment of ocular diseasesH LUNDBECK AS·Filed 2018·Granted May 4, 2021·7 cites·13 claims
- 0789US10562962B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2018·Granted Feb 18, 2020·6 cites·11 claims
- 0889US10487142B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2019·Granted Nov 26, 2019·5 cites·3 claims
- 0988US10472415B2Antibodies specific for hyperphosphorylated tau and methods of useH LUNDBECK AS·Filed 2017·Granted Nov 12, 2019·5 cites·3 claims
- 1088US2025257124A1Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2024·Application pending·0 cites
- 1187US11739140B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2021·Granted Aug 29, 2023·1 cites·12 claims
- 1285US6358710B1Humanized antibodies that bind to the antigen bound by antibody NR-LU-13NEORX CORP·Filed 1997·Granted Mar 19, 2002·59 cites·7 claims
- 1378US12129289B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2021·Granted Oct 29, 2024·0 cites·15 claims
- 1464US2009094715A1Methods of use of antibodies with reduced immunogenicity or toxicityPONIARD PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1562US2005008635A1Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 and their use in pretargeting methodsNEORX CORP·Filed 2004·Application pending·0 cites
- 1656US2003119078A1Method of reducing immunogenicity of toxicity of an antibody of IgG classNEORX CORP·Filed 2002·Application pending·0 cites
- 1746US2022187322A1Use of a ps396 assay to diagnose tauophatiesH LUNDBECK AS·Filed 2020·Application pending·0 cites
- 1841US2004122216A1Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organsFiled 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →